US 7,575,872 B2
	Antibody against von Willebrand factor cleaving enzyme and assay system using the same
Kenji Soejima, Kumamoto (Japan); Noriko Mimura, Kumamoto (Japan); Hiroaki Maeda, Kumamoto (Japan); Chikateru Nozaki, Kumamoto (Japan); Takayoshi Hamamoto, Kumamoto (Japan); and Tomohiro Nakagaki, Kumamoto (Japan)
Assigned to Juridical Foundation The Chemo-Sero-Therapeutic Research Institute, Kumamoto (Japan)
Appl. No. 10/529,009 PCT Filed Sep. 25, 2003, PCT No. PCT/JP03/12280 § 371(c)(1), (2), (4) Date Mar. 24, 2005, PCT Pub. No. WO2004/029242, PCT Pub. Date Apr. 08, 2004.
Claims priority of application No. 2002-279924 (JP), filed on Sep. 25, 2002; and application No. 2002-377569 (JP), filed on Dec. 26, 2002.
Prior Publication US 2006/0251655 A1, Nov. 09, 2006
Int. Cl. G01N 33/53 (2006.01); C12N 5/20 (2006.01); C07K 16/00 (2006.01); C07K 16/28 (2006.01)

U.S. Cl. 435—7.1  [435/326; 530/387.1; 530/388.1; 530/388.25]

8 Claims

1. An isolated monoclonal antibody produced by a hybridoma selected from the group consisting of hybridoma line WHIO (accession number FERM BP-08174), hybridoma line WH63.1 (accession number FERM BP-08175), hybridoma line WHS40.3 (accession number FERM BP-08176), hybridoma line Pep4H 34.1 (accession number FERM BP-08177), hybridoma line WH2-22-1A (accession number FERM BP-08483), hybridoma line WH2-1-1 (accession number FERM BP-08484), hybridoma line WH2-11-1 (accession number FERM BP-08485), hybridoma line Pep6-6A (accession number FERM BP-08474) and hybridoma line PEP4-5B-1 (accession number FERM BP-08475).